EUVIMEDEUVIMED entdecken
Crossref

Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?

AC Duarte, S Alegria, F Vinagre, F Ferreira, A Cordeiro

ARP Rheumatology · 2024

DOI: 10.63032/bbmb6759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ARP Rheumatology, 2024. Verfasst von AC Duarte und 4 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Duarte, A., Alegria, S., Vinagre, F., Ferreira, F., & Cordeiro, A. (2024). Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?. ARP Rheumatology. https://doi.org/10.63032/bbmb6759

Vancouver

Duarte A, Alegria S, Vinagre F, Ferreira F, Cordeiro A. Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?. ARP Rheumatology. 2024. doi:10.63032/bbmb6759

BibTeX
@article{Duarte2024,
  author = {Duarte, AC and Alegria, S and Vinagre, F and Ferreira, F and Cordeiro, A},
  title = {Can subcutaneous treprostinil be an alternative for treating pulmonary hypertension in patients with systemic sclerosis-related interstitial lung disease?},
  journal = {ARP Rheumatology},
  year = {2024},
  doi = {10.63032/bbmb6759}
}
Kostenlos starten →